-+ 0.00%
-+ 0.00%
-+ 0.00%

Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $95

Benzinga·05/02/2025 12:06:42
Listen to the news
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $100 to $95.